Login to Your Account

Historic milestone for Zealand Pharma as FDA approves diabetes combo Lixilan

By Cormac Sheridan
Staff Writer

Tuesday, November 22, 2016

DUBLIN – Zealand Pharma A/S has attained the most significant milestone in its 18-year history, the FDA approval of Sanofi SA's type 2 diabetes combo product, Soliqua 100/33.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription